Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT00184626

Femme et Homme

  • | Pays :
  • Turkey
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This trial is conducted in Asia. The aim of the trial is to compare the glycaemic control of Insulin glargine versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in combination with metformin in subjects with Type 2 Diabetes.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 2

Liens